Wary European Drugmakers Think They Can Avoid Trump’s Latest Tariffs
European companies, a major source of U.S. medicines, are hopeful [...]
In an expansion of its previous…
In an expansion of its previous moves to cut the [...]
Biogen has discontinued all gene…
Biogen has discontinued all gene therapy programs using adeno-associated virus [...]
AstraZeneca is the latest Big…
AstraZeneca is the latest Big Pharma to unveil a digital [...]
Together, the two programs…
Together, the two programs represent a nine-figure investment from the [...]
Amgen has spent the last three…
Amgen has spent the last three decades building out its [...]
The 100% rate floated in Donald…
The 100% rate floated in Donald Trump’s new communique on [...]
Celltrion is buying an Eli Lilly…
Celltrion is buying an Eli Lilly plant in the U.S. [...]
While Eli Lilly is rethinking its…
While Eli Lilly is rethinking its biotech incubator plans in [...]
U.S. biotechs are increasingly…
U.S. biotechs are increasingly reluctant to license their drugs to [...]